Acquisition by Laxminarayan Bhat of 443000 shares of Reviva Pharmaceuticals at 6.74 subject to Rule 16b-3
| RVPHW Stock | USD 0.14 0.01 7.69% |
Slightly above 56% of all Reviva Pharmaceuticals' sophisticated investors are looking to take a long position. The analysis of overall sentiment of trading Reviva Pharmaceuticals Holdings stock suggests that some investors are interested at this time. Reviva Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Reviva Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Reviva |
Filed transaction by Reviva Pharmaceuticals Holdings Director, 10 Percent Owner, Officer President And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Reviva Pharmaceuticals Fundamental Analysis
We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Reviva Pharmaceuticals is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Reviva Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reviva Pharmaceuticals Related Equities
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.